ARTICLE | Clinical News
Tetrabenazine regulatory update
May 2, 2005 7:00 AM UTC
Prestwick submitted an NDA for tetrabenazine to treat chorea associated with Huntington's disease (HD). The selective inhibitor of vesicular monoamine transporter (VMAT2) has Orphan Drug and Fast Trac...